Cardiac hypertrophy and
myocardial infarction (MI) are two etiologically different disease forms with varied pathological characteristics. However, the precise molecular mechanisms and specific causal
proteins associated with these diseases are obscure to date. In this study, a comparative cardiac
proteome profiling was performed in Wistar rat models for diseased and control (
sham) groups using two-dimensional difference gel electrophoresis followed by matrix-assisted
laser desorption/ionization tandem time-of-flight mass spectrometry.
Proteins were identified using
Protein Pilot™ software (version 4.0) and were subjected to stringent statistical analysis. Alteration of key
proteins was validated by Western blot analysis. The differentially expressed
protein sets identified in this study were associated with different functional groups, involving various metabolic pathways, stress responses, cytoskeletal organization, apoptotic signaling and other miscellaneous functions. It was further deciphered that altered energy metabolism during
hypertrophy in comparison to MI may be predominantly attributed to induced
glucose oxidation level, via reduced phosphorylation of
pyruvate dehydrogenase E1 component subunit β (PDHE1-B)
protein during
hypertrophy. This study reports for the first time the global changes in rat cardiac
proteome during two etiologically different
cardiac diseases and identifies key signaling regulators modulating ontogeny of these two diseases culminating in
heart failure. This study also pointed toward differential activation of PDHE1-B that accounts for upregulation of
glucose oxidation during
hypertrophy. Downstream analysis of altered
proteome and the associated modulators would enhance our present knowledge regarding altered pathophysiology of these two etiologically different
cardiac disease forms.